Each week, experienced entrepreneurs and innovators come to Stanford University to candidly share lessons they’ve learned while developing, launching and scaling disruptive ideas. The Entrepreneurial Thought Leaders Series (ETL) is produced by the Stanford Technology Ventures Program (STVP) and published on eCorner by STVP.
Midway through a M.D./Ph.D program at UCLA, Alice Zhang made a discovery that she felt could reverberate far beyond the halls of academia. So she shifted directions, leaving her Ph.D program to found Verge Genomics, a biomedical firm that aims to unite genetic research and artificial intelligence in service of drug discovery. She describes how AI can revolutionize the drug discovery process, and reframes risk-taking as a simple series of optimistic next steps.
